When the victim becomes the villain: Platelets as drivers of immune dysregulation in ITP
Top Cited Papers
Open Access
- 19 August 2025
- journal article
- review article
- Published by Elsevier in Journal of Translational Autoimmunity
- Vol. 11, 100309
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Autoreactive B cells in autoimmune diseases: Mechanisms, functions and clinical implicationsAutoimmunity Reviews, 2025
- Clinical characteristics, treatment, and outcomes of nivolumab induced immune thrombocytopeniaInvestigational New Drugs, 2024
- Cadmium activates the innate immune system through the AIM2 inflammasomeChemico-Biological Interactions, 2024
- Cytotoxic T lymphocyte‐associated antigen‐4 (CTLA-4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP)Blood Research, 2024
- Primary and secondary immune thrombocytopenia (ITP): Time for a rethinkBlood Reviews, 2023
- Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectivesAnnals of Hematology, 2022
- Procoagulant platelets: Generation, characteristics, and therapeutic targetJournal of Clinical Laboratory Analysis, 2021
- Pathogenesis of immune thrombocytopenia in common variable immunodeficiencyAutoimmunity Reviews, 2020
- CD4+ T cell phenotypes in the pathogenesis of immune thrombocytopeniaCellular Immunology, 2020
- Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytesExperimental Hematology, 2006